| 08:00-08:30 | 专题报告 |
儿童细菌性肺炎抗菌药物治疗策略 |
|
||||
| 08:30-09:00 | 专题报告 |
基于人工智能药物性肝损的研究 |
|
||||
| 09:00-09:05 | 讨论 |
集体答疑、讨论 |
|||||
| 09:05-09:13 | 大会发言 |
Whole-Exome Association Study and Clinical Analysis of Pediatric Drug-Induced Liver Injury |
|
||||
| 09:13-09:21 | 大会发言 |
基于患者特征驱动模型优选的儿童精准给药决策平台PreciDose的构建与应用 |
|
||||
| 09:21-09:29 | 大会发言 |
Models Integrating Disease Heterogeneity and MPA Exposure Predict Systemic and Renal Efficacy of Mycophenolate in Pediatric Lupus Nephritis |
|
||||
| 09:29-09:37 | 大会发言 |
儿童原发性肾病综合征利妥昔单抗治疗不良事件相关性的融合性分析——基于117例患儿的不良事件发生因素研究 |
|
||||
| 09:37-09:45 | 大会发言 |
117例儿童原发性肾病综合征利妥昔单抗治疗相关不良事件及危险因素探讨 |
|
||||
| 09:45-09:53 | 大会发言 |
基于群体药代动力学模型及药效学的中国难治性癫痫儿童氯巴占个体化给药方案优化 |
|
||||
| 09:53-10:01 | 大会发言 |
Free Mycophenolic Acid Exposure for Therapeutic Drug Monitoring in Pediatric Lupus Nephritis: Associations with Treatment Response and Hematologic Toxicity |
|
||||
| 10:01-10:09 | 大会发言 |
模型指导与经验性西罗莫司给药治疗儿童难治性淋巴管畸形的临床结局比较:一项基于马氏距离匹配的前瞻性队列研究 |
|
||||
| 10:09-10:17 | 大会发言 |
基于真实世界大样本数据的儿童西罗莫司血药浓度机器学习预测模型构建、验证与在线临床决策支持工具开发 |
|
||||
| 10:17-10:25 | 大会发言 |
基于AI与分子模拟技术的ALK突变靶向药物精准用药评价体系构建研究 |
|
||||
| 10:25-10:33 | 大会发言 |
Web-Based Nomogram for Predicting the risk of Subtherapeutic Infliximab Trough Levels in Pediatric Crohn's Disease: Personalized Risk Stratification and Data-Driven Management of Infliximab Therapy |
|
||||
| 10:33-10:41 | 大会发言 |
基于多组学标志物构建肿瘤坏死因子α抑制剂治疗幼年特发性关节炎疗效预测模型 |
|
||||
| 10:41-10:49 | 大会发言 |
临床药师主导的抗菌药物路径管理在儿童阑尾切除术围手术期的应用:一项单中心回顾性队列研究 |
|
||||
| 10:49-10:57 | 大会发言 |
Cenobamate治疗儿童及成人药物难治性癫痫的疗效与安全性:一项系统评价与Meta分析 |
|
||||
| 10:57-11:05 | 大会发言 |
Blood metabolite-based machine learning models for risk prediction of neonatal thalassemia disease |
|
||||||||||||||
| 11:05-11:20 | 大会发言 |
病例报告:拉考沙胺口服溶液致癫痫患儿药物性皮炎1例分析 |
|
||||||||||||||
| 11:20-11:50 | 讨论 |
集体答疑,讨论 |
|
||||||||||||||
| 13:30-14:00 | 专题报告 |
儿童CNS自身免疫性疾病的药物治疗进展 |
|
||||
| 14:00-14:30 | 专题报告 |
变态反应疑难和罕见病药物研发进展 |
|
||||
| 14:30-15:00 | 专题报告 |
脑疾病基因治疗技术的开发和应用 |
|
||||
| 15:00-15:05 | 讨论 |
集体答疑、讨论 |
|||||
| 15:05-15:13 | 大会发言 |
利妥昔单抗对儿童自身免疫性疾病患者免疫球蛋白G和免疫球蛋白M水平的影响:一项队列研究 |
|
||||
| 15:13-15:21 | 大会发言 |
Vamorolone治疗杜氏肌营养不良疗效与安全性的回顾性研究 |
|
||||
| 15:21-15:29 | 大会发言 |
Single-Nucleus Transcriptomic Profiling Reveals Cellular Landscape and Potential Molecular Mechanisms of Tacrolimus-Associated Cardiotoxicity in Pediatric Patients |
|
||||
| 15:29-15:37 | 大会发言 |
伊马替尼在慢性粒细胞白血病患者中群体药动学分析及体外CYP3A4多态性研究 |
|
||||
| 15:37-15:45 | 大会发言 |
罕见病超说明书用药专家共识(2026版)制定及其在儿童罕见病规范化治疗中的意义 |
|
||||
| 15:45-15:53 | 大会发言 |
基于CYP2D6遗传信息的注意缺陷多动障碍儿童托莫西汀群体药动学研究及个体化给药 |
|
||||
| 15:53-16:01 | 大会发言 |
基于聚合物PBAE递送CRISPR/Cas9靶向敲除肺血管内皮细胞STING基因治疗SAVI疾病的研究 |
|
||||
| 16:01-16:09 | 大会发言 |
Gestational Age-Dependent Differences in Umbilical Cord-Derived Stromal Cells: A Systematic Review of Preterm Versus Term Human Studies |
|
||||
| 16:09-16:17 | 大会发言 |
ABCC2 rs2273697 is an independent determinant of tacrolimus intra‐patient variability during the first year after kidney transplantation |
|
||||
| 16:17-16:25 | 大会发言 |
酸枣仁汤治疗肝郁血虚证儿童失眠障碍的随机对照试验及药代动力学-网络药理学整合研究 |
|
||||
| 16:25-16:33 | 大会发言 |
Melatonin Precision Dosing in Pediatric Sleep Disorders: Integrating CYP1A2 Pharmacogenomics and Individualized Pharmacokinetic Modeling |
|
||||
| 16:33-16:41 | 大会发言 |
托珠单抗治疗儿童慢性期热性感染相关性癫痫综合征:一项前瞻性队列研究 |
|
||||
| 16:41-16:49 | 大会发言 |
Neuroprotection and safety profile of Astragalus membranaceus extract TA-65 in neonatal hypoxic-ischemic brain damage by activating mitochondrial telomerase reverse transcriptase: Evidence from in vitro and in vivo studies |
|
||||
| 16:49-16:57 | 大会发言 |
粪菌群移植治疗孤独症的长期疗效及药理机制探索:基于RAINMAN前瞻性队列 |
|
||||
| 16:57-17:05 | 大会发言 |
Single-cell transcriptomic atlas unravels renal cell heterogeneity and intercellular communication in adriamycin-induced nephropathy |
|
||||
| 17:05-17:13 | 大会发言 |
重组人生长激素通过GH/IGF-1轴抑制甲基丙二酸血症神经元凋亡的机制研究 |
|
||||
| 17:13-17:20 | 讨论 |
集体答疑、讨论 |
|||||